交易 Eyenovia, Inc. - EYEN CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | - | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.024068% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | 0.001846% | ||||||||
隔夜费时间 | 21:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|
Eyenovia, Inc. Events
時間(協調世界時) (UTC) | 國家 | 事件 |
---|---|---|
No events scheduled |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
总收入 | 14 | 2 | 0 | 0 | 0 |
收入 | 14 | 2 | 0 | ||
总营业费用 | 26.4403 | 21.7892 | 21.3085 | 17.2564 | 5.13237 |
销售/一般/行政费用,总计 | 10.7842 | 7.69759 | 7.20051 | 6.13618 | 1.31564 |
研究与开发 | 14.2979 | 13.1962 | 14.0927 | 11.1011 | 3.79127 |
Depreciation / Amortization | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
营业收入 | -12.4403 | -19.7892 | -21.3085 | -17.2564 | -5.13237 |
利息收入(费用),非经营净值 | -0.38524 | 0.00936 | 0.15179 | 0.00334 | 0.00238 |
税前净收入 | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
税后净收入 | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
未计算非常项目前的净收益 | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
净收入 | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
普通股股东可获收益 (不含非经常性项目) | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
普通股股东可获收益 (含非經常性項目) | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
摊薄调整 | |||||
摊薄净收入 | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
摊薄后加权平均股 | 26.3241 | 21.0547 | 14.3497 | 9.47671 | 9.93677 |
扣除特别项目的每股摊薄盈利 | -0.48543 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
Dividends per Share - Common Stock Primary Issue | |||||
每股正常摊薄盈利 | -0.50303 | -0.93898 | -1.47437 | -1.82058 | -0.51626 |
非常规项目总计 | 0 | ||||
收入成本,共计 | 1.6 | 0.8 | |||
毛利 | 12.4 | 1.2 | |||
其他,净值 | 0.04718 | 0.01 | |||
异常费用(收入) | -0.46335 |
Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 10 | 0 |
收入 | 0 | 0 | 0 | 10 | 0 |
收入成本,共计 | 0 | 0 | 0 | 0 | 0 |
毛利 | 0 | 0 | 0 | 10 | 0 |
总营业费用 | 7.23023 | 7.12146 | 7.18755 | 6.88673 | 5.46171 |
销售/一般/行政费用,总计 | 3.35335 | 3.53459 | 3.47497 | 3.7115 | 2.373 |
研究与开发 | 3.87688 | 3.58687 | 3.71258 | 3.17523 | 3.55207 |
营业收入 | -7.23023 | -7.12146 | -7.18755 | 3.11327 | -5.46171 |
利息收入(费用),非经营净值 | -0.14905 | -0.15102 | -0.14505 | -0.18519 | -0.11861 |
其他,净值 | 0.07028 | 0.03338 | -0.00707 | 0.05519 | 0.01173 |
税前净收入 | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
税后净收入 | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
未计算非常项目前的净收益 | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
净收入 | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
普通股股东可获收益 (不含非经常性项目) | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
普通股股东可获收益 (含非經常性項目) | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
摊薄净收入 | -7.309 | -7.2391 | -7.33967 | 2.98328 | -5.5686 |
摊薄后加权平均股 | 34.6318 | 33.6449 | 30.0082 | 27.977 | 26.0535 |
扣除特别项目的每股摊薄盈利 | -0.21105 | -0.21516 | -0.24459 | 0.10663 | -0.21374 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.21105 | -0.21516 | -0.24459 | 0.10663 | -0.23152 |
异常费用(收入) | 0 | 0 | -0.46335 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
流动资产总额 | 29.8769 | 33.3913 | 14.3493 | 19.861 | 5.28666 |
现金和短期投资 | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
Cash | 19.4618 | 28.3718 | 14.1526 | 19.7282 | 5.24951 |
Prepaid Expenses | 0.38663 | 0.2898 | 0.07737 | 0.13276 | 0.03715 |
Total Assets | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
Property/Plant/Equipment, Total - Net | 1.27123 | 0.39638 | 0.23054 | 0.03674 | 0.02796 |
Property/Plant/Equipment, Total - Gross | 1.59963 | 0.57329 | 0.31203 | 0.10289 | 0.07498 |
Accumulated Depreciation, Total | -0.32841 | -0.17691 | -0.08149 | -0.06615 | -0.04702 |
Total Current Liabilities | 11.1725 | 18.1984 | 2.91166 | 3.09884 | 0.55265 |
Accounts Payable | 1.6141 | 1.46167 | 1.54136 | 1.50952 | 0.24638 |
Accrued Expenses | 2.32693 | 2.57974 | 1.31332 | 1.56769 | 0.29529 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.08109 | 14.0594 | 0.05698 | 0.02163 | 0.01098 |
Total Liabilities | 11.1924 | 18.6029 | 2.95701 | 3.14043 | 0.55265 |
Total Long Term Debt | 0 | 0.36581 | 0 | 0 | 0 |
Other Liabilities, Total | 0.01995 | 0.03868 | 0.04535 | 0.04158 | 0 |
Total Equity | 20.4666 | 15.3039 | 11.7406 | 16.8751 | 5.09067 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Preferred Stock - Non Redeemable, Net | 0.00046 | ||||
Common Stock | 0.00284 | 0.0025 | 0.00171 | 0.00115 | 0.00026 |
Additional Paid-In Capital | 110.683 | 92.7423 | 69.41 | 53.3882 | 24.3511 |
Retained Earnings (Accumulated Deficit) | -90.2193 | -77.4409 | -57.6711 | -36.5143 | -19.2612 |
Total Liabilities & Shareholders’ Equity | 31.6591 | 33.9068 | 14.6976 | 20.0155 | 5.64332 |
Total Common Shares Outstanding | 28.4266 | 24.9786 | 17.1007 | 11.469 | 9.93677 |
Other Long Term Assets, Total | 0.51098 | 0.11904 | 0.1178 | 0.1178 | 0.3287 |
应收账款总额,净额 | 2.14885 | 3.11798 | 0.09523 | ||
Other Current Assets, Total | 7.87953 | 1.61173 | 0.02408 | ||
Current Port. of LT Debt/Capital Leases | 7.15037 | 0.09754 | |||
Long Term Debt | 0 | 0.36581 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
流动资产总额 | 30.3986 | 29.8769 | 23.4593 | 29.495 | 28.0252 |
现金和短期投资 | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
Cash | 26.7163 | 19.4618 | 13.5009 | 27.1768 | 24.907 |
应收账款总额,净额 | 1.85222 | 2.14885 | 1.25767 | 1.17134 | 1.17891 |
Prepaid Expenses | 1.79656 | 0.38663 | 0.77768 | 1.04895 | 1.089 |
Other Current Assets, Total | 0.03358 | 7.87953 | 7.92312 | 0.09787 | 0.85025 |
Total Assets | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
Property/Plant/Equipment, Total - Net | 1.37036 | 1.27123 | 1.4132 | 0.96888 | 0.70742 |
Other Long Term Assets, Total | 8.41907 | 0.51098 | 0.11904 | 0.11904 | 0.11904 |
Total Current Liabilities | 10.3788 | 11.1725 | 20.7194 | 14.5598 | 16.3656 |
Accounts Payable | 1.53476 | 1.6141 | 1.68473 | 1.66763 | 1.81512 |
Accrued Expenses | 1.05726 | 2.32693 | 1.68645 | 1.86687 | 1.7253 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 7.74012 | 7.15037 | 7.28204 | 0.95976 | 0.78382 |
Other Current Liabilities, Total | 0.04662 | 0.08109 | 10.0662 | 10.0656 | 12.0414 |
Total Liabilities | 10.3939 | 11.1924 | 20.7454 | 21.5924 | 16.7115 |
Total Long Term Debt | 0 | 0 | 0 | 6.99489 | 0.30729 |
Long Term Debt | 0 | 0 | 6.99489 | 0.30729 | |
Other Liabilities, Total | 0.01508 | 0.01995 | 0.02606 | 0.03763 | 0.03863 |
Total Equity | 29.7942 | 20.4666 | 4.24614 | 8.99056 | 12.1401 |
Redeemable Preferred Stock | 0 | 0 | 0 | ||
Common Stock | 0.00317 | 0.00284 | 0.0026 | 0.0026 | 0.00256 |
Additional Paid-In Capital | 127.35 | 110.683 | 97.4461 | 96.6219 | 94.9301 |
Retained Earnings (Accumulated Deficit) | -97.559 | -90.2193 | -93.2026 | -87.634 | -82.7926 |
Total Liabilities & Shareholders’ Equity | 40.1881 | 31.6591 | 24.9916 | 30.5829 | 28.8517 |
Total Common Shares Outstanding | 31.6984 | 28.4266 | 25.9632 | 25.9466 | 25.6236 |
- 年度
- 每季度
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
净收入/起跑线 | -12.7784 | -19.7699 | -21.1568 | -17.2531 | -5.12999 |
经营活动产生的现金 | -20.8744 | -6.38428 | -18.9193 | -13.1111 | -4.73111 |
经营活动产生的现金 | 0.22156 | 0.09542 | 0.01534 | 0.01913 | 0.02547 |
非现金物品 | 2.43593 | 2.48317 | 2.51194 | 1.61547 | 0.41231 |
Cash Taxes Paid | |||||
已付现金利息 | 0.22717 | 0.01397 | |||
营运资金的变化 | -10.7535 | 10.807 | -0.28984 | 2.50737 | -0.0389 |
投资活动产生的现金 | -1.61852 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
资本支出 | -1.22658 | -0.26126 | -0.16664 | -0.02791 | -0.01023 |
其他投资现金流量项目,总计 | -0.39194 | ||||
融资活动产生的现金 | 21.458 | 20.8648 | 13.5104 | 27.6177 | 6.60357 |
股票的发行(报废),净额 | 14.7299 | 20.8766 | 13.5104 | 27.6177 | 6.60357 |
现金净变化 | -1.03498 | 14.2192 | -5.5756 | 14.4787 | 1.86222 |
债务的发行(退还),净额 | 6.72802 | -0.01186 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -7.33967 | -12.7784 | -15.7617 | -10.1931 | -5.35167 |
Cash From Operating Activities | -8.1844 | -20.8744 | -14.9978 | -9.90314 | -4.57385 |
Cash From Operating Activities | 0.07543 | 0.22156 | 0.14825 | 0.07524 | 0.03328 |
Non-Cash Items | 0.9352 | 2.43593 | 1.65033 | 1.30978 | 0.65691 |
Cash Interest Paid | 0.09559 | 0.22717 | 0.13184 | 0.07046 | 0.004 |
Changes in Working Capital | -1.85537 | -10.7535 | -1.03471 | -1.0951 | 0.08763 |
Cash From Investing Activities | -0.20766 | -1.61852 | -1.16507 | -0.64774 | -0.34432 |
Capital Expenditures | -0.17457 | -1.22658 | -1.16507 | -0.64774 | -0.34432 |
Cash From Financing Activities | 15.6465 | 21.458 | 9.16692 | 9.3559 | 1.45339 |
Financing Cash Flow Items | -0.08339 | 0 | |||
Issuance (Retirement) of Stock, Net | 15.8417 | 14.7299 | 2.28079 | 2.23408 | 1.53099 |
Issuance (Retirement) of Debt, Net | -0.11179 | 6.72802 | 6.88612 | 7.12182 | -0.0776 |
Net Change in Cash | 7.25442 | -1.03498 | -6.99596 | -1.19499 | -3.46478 |
Cash Taxes Paid | 0 | 0 | |||
Other Investing Cash Flow Items, Total | -0.0331 | -0.39194 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Grant (Stuart M) | Individual Investor | 14.2096 | 5132677 | 21753 | 2022-12-30 | LOW |
Eshelman (Fredric N) | Individual Investor | 4.4624 | 1611872 | -6963 | 2022-11-10 | LOW |
Ianchulev (Tsontcho M.D.) | Individual Investor | 3.3016 | 1192562 | -21316 | 2022-12-27 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 2.5451 | 919322 | -8433 | 2022-12-31 | LOW |
Medical Strategy GmbH | Investment Advisor | 1.922 | 694259 | 0 | 2022-09-30 | LOW |
Avenue Capital Group | Investment Advisor/Hedge Fund | 1.5166 | 547807 | 547807 | 2022-12-31 | HIGH |
Mario (Ernest B) | Individual Investor | 1.0595 | 382706 | 6963 | 2021-11-17 | LOW |
Columbia Threadneedle Investments (US) | Investment Advisor/Hedge Fund | 0.9314 | 336432 | 336432 | 2022-12-31 | LOW |
Palisade Capital Management, LLC | Investment Advisor/Hedge Fund | 0.8721 | 315029 | 315029 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.7987 | 288500 | 24400 | 2022-12-31 | HIGH |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.72 | 260067 | 6056 | 2022-12-31 | LOW |
Millennium Management LLC | Hedge Fund | 0.2507 | 90568 | 14153 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.2035 | 73517 | 11900 | 2022-12-31 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 0.1954 | 70581 | 1159 | 2022-12-31 | LOW |
Mather (Charles E IV) | Individual Investor | 0.1953 | 70544 | 22222 | 2022-06-16 | LOW |
Clasby (Jennifer G) | Individual Investor | 0.1842 | 66537 | 10835 | 2021-06-17 | |
Lee (Kenneth B Jr) | Individual Investor | 0.1787 | 64544 | 22222 | 2022-06-16 | LOW |
Bridgeway Capital Management, LLC | Investment Advisor | 0.1326 | 47900 | 0 | 2022-12-31 | LOW |
Oak Family Advisors, LLC | Investment Advisor/Hedge Fund | 0.1276 | 46073 | -13113 | 2022-12-31 | MED |
BNY Mellon Asset Management | Investment Advisor | 0.1228 | 44374 | -1136 | 2022-12-31 | LOW |
交易計算器
如果您在特定日期(选择一个日期)开立差价合约交易并在不同日期(选择一个日期)关闭交易,计算您的假设盈亏。
貿易佣金
0
- 1:1
杠杆
1:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Eyenovia, Inc. Company profile
关于 Eyenovia Inc.
Eyenovia, Inc.是一家处于临床阶段的眼科公司。 该公司正在开发一条基于微剂量阵列打印(MAP)平台技术的治疗管道。 其管线主要集中在针对渐进性近视、老花眼和散瞳的微剂量药物的后期开发。 该公司的候选产品包括MydCombi、MicroPine和MicroLine。 MydCombi是一种用于药物性眼球扩张(眼球扩张)的组合微制剂产品(苯肾上腺素-托吡卡胺)。 MicroPine是一种治疗进行性近视的局部疗法,这是一种与病理性轴伸长和巩膜拉伸有关的眼底疾病。 微线是一种候选药物,它正在开发微剂量的皮罗卡平,这是一种眼科药物,可以按剂量诱导瞳孔收缩,即瞳孔收缩。
Industry: | Pharmaceuticals (NEC) |
295 Madison Ave Ste 2400
NEW YORK
NEW YORK 10017
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。